Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Sarcoma × Urine Specimen Collection × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 2 Neoplasms 2 Lung Neoplasms 2 Carcinoma, Renal Cell 2 Weight Loss 1 Triple Negative Breast Neoplasms 1 Sleep Apnea Syndromes 1 Sezary Syndrome 1 Sarcoma 1 Overweight 1 Obesity, Morbid 1 Obesity 1 Non-Muscle Invasive Bladder Neoplasms 1 Mycosis Fungoides 1 Multiple Myeloma 1 Lymphoma, T-Cell, Cutaneous 1 Hypertension 1 Hyperlipidemias 1 Hemangioma 1 Gastroesophageal Reflux 1 Eczema 1 Digestive System Diseases 1 Diabetes Mellitus, Type 2 1 Diabetes Mellitus 1 Dermatitis, Atopic 1 Collagen Diseases 1 Breast Neoplasms 1

Interventions

Gene Expression Profiling 9 Surveys and Questionnaires 7 Blood Specimen Collection 7 Surgical Procedures, Operative 6 Polymerase Chain Reaction 6 Microarray Analysis 4 Immunohistochemistry 4 Base Sequence 4 Trabectedin 3 Therapeutics 3 Reverse Transcriptase Polymerase Chain Reaction 3 Radiation 3 Psychiatric Rehabilitation 3 Observation 3 Drug Therapy 3 Radiotherapy 2 Patient Reported Outcome Measures 2 Molecular Diagnostic Techniques 2 Methods 2 In Situ Hybridization, Fluorescence 2 Gene Rearrangement 2 DNA Methylation 2 Amplified Fragment Length Polymorphism Analysis 2 trastuzumab deruxtecan 1 pazopanib 1 liposomal doxorubicin 1 fluorodopa F 18 1 eribulin 1 Watchful Waiting 1 Urine Specimen Collection 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06482957 2025-09-19

CAUSAL

Vanderbilt-Ingram Cancer Center

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡